Catalysts in anticancer therapies often function by facilitating the activation or deactivation of specific molecules involved in cancer cell growth. For example, metal complexes can act as catalysts to produce reactive oxygen species (ROS) that induce apoptosis in cancer cells. Additionally, enzyme-like catalysts can be designed to selectively activate prodrugs in the vicinity of cancer cells, thereby reducing systemic toxicity.
